The predicted increase in spontaneous and/or GTPase‐stimulated kinase activation would therefore be compatible with a clinical outcome of macrocephaly and intellectual disability or developmental delay and also seizures, as it is observed with known PAK1 variants located in this autoinhibitory domain.12, 13, 14. Here, PAK1 is linked to Global developmental delay.